Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
Ritsuko Iwanaga(University of Colorado Denver), Heide L. Ford(University of Colorado Denver)
Cited by 90
Related Papers
Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
|Journal of Mammary Gland Biology and Neoplasia|2010|972
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
|Nature Communications|2018|81
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3
|Breast Cancer Research|2014|56
SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma
|Nature Communications|2023|12